Developer of a social event discovery platform designed to improve the way people make plans.
Developer of a social event discovery platform designed to improve the way people make plans.
Application Software📍 New York, NYFounded 2014
Current Valuation
$3.6B
as of 2025-Q2
UNICORN
QL Price
$3.3B
-10% vs last round
QuantLogix's current estimate for Fever, published 2026-09-27 — below the last disclosed round of $3.6B (2025-Q2).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$3.6B
2025-Q2
weight 0.42
Secondary market print
$3.0B
2026-06-27
weight 0.58
How this price has held up
No round has priced for Fever since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Fever, 2026-09-27 (930a34da61741f37).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Fever going public?
No. Fever is private and has not filed to go public. There is no S-1 on file.
What is Fever's valuation in 2026?
Fever is valued at $3.6B as of 2025-Q2, set by its PE Growth/Expansion ($100M, Jun 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Fever filed an S-1?
No public S-1 is on file for Fever.
How much has Fever raised?
Fever has raised $509.29M in total, most recently a PE Growth/Expansion of $100M in Jun 2025.
Is Fever publicly traded — can you buy Fever stock?
No. Fever is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Fever on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2014
HQ
New York, NY
Employees
3,954
Total Raised
$509.29M
Last Round
PE Growth/Expansion — $100M (Jun 2025)
IPO Status
private
Fundraising Status
PE Growth/Expansion · $100M · 1y 3mo ago
privateTotal raised $509.29M
Secondary Market
Implied price / share
$4.62
Last round price / share
$5.54
vs last round
-16.6%
Open interest
17
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
PE Growth/Expansion
$100M
Jun 2025
—
$3.6B
Talent Signal
Hiring trend
▶ Hiring steady
+6% vs 2026-08
Open roles
604
via greenhouse
Product-build share
9%
engineering, research, product, design
Trajectory
steady
go-to-market push — Only 9% of open roles build product — hiring is concentrated in sales/marketing/ops (246 of 604 open roles are other).
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
AI Engineering LeadAI Engineer – Internal Automation (Forward Deployed)AI Senior DesignerAI Staff EngineerBecas de Excelencia - EngineeringCreative Director (Experiences & Events)
Counted from Fever's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Consumer Goods & Software
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q2. Refreshed quarterly.